相关实验视频

Updated: Jun 15, 2025

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

针对非小细胞肺癌免疫治疗的瘤微环境

Lei Wang^1,2, Qingzhu Jia^2,3, Qian Chu¹

¹Department of Oncology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China.

Chinese medical journal pulmonary and critical care medicine

|August 22, 2024

概括

瘤微环境 (TME) 对癌症生长和治疗反应至关重要. 准TME免疫细胞,特别是在非小细胞肺癌中,显示出更有效的癌症治疗的希望.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
癌症生物学癌症生物学

背景情况:

瘤微环境 (TME) 包含多种不同的细胞和非细胞组成部分.
瘤细胞和TME之间的相互作用影响癌症的发病,进展和治疗结果.
在TME内的免疫细胞,分为适应性和先天性免疫,是癌症治疗的关键目标.

研究的目的:

审查非小细胞肺癌 (NSCLC) 中TME的异质性.
总结在临床前和临床环境中针对TME的进展.
讨论TME在免疫治疗中的预测作用和双特异抗体的潜力.

主要方法:

临床前和临床研究的文献综述.
在NSCLC中分析TME异质性.
免疫细胞向策略的探索.
在癌症免疫治疗中对双特异性抗体的评估.

主要成果:

在NSCLC中,TME表现出显著的异质性.
针对TME组件在各种癌症研究中显示出有前途.
TME特征可以预测免疫治疗反应.
双特异性抗体显示出增强免疫疗法疗效的潜力.

结论:

了解TME异质性对于开发有效的癌症治疗至关重要.
针对TME内的免疫细胞提供了一个有前途的治疗途径.
双特异性抗体代表了癌症免疫疗法的重大进展.

关键词:

适应性免疫细胞适应性免疫细胞生物标志物生物标志物双特异性抗体双特异性抗体免疫治疗是一种免疫疗法.天生的免疫细胞是天生的免疫细胞.瘤微环境是一个微环境.

更多相关视频

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...